tbuckley/cabot-search huggingface dataset:
Office treatment of rectal and anal diseases
Authors: G. V. Rodkey
Journal: JAMA (1973)

Considering the role of the rectum and anus as a conduit for excretion of gaseous, liquid, or solid waste with high concentrations of infective bacteria, their functions are remarkably efficient and trouble-free. In fact, discrimination, continence, and defecation are accomplished largely at reflex levels with acute consciousness of anorectal function being reserved for states of deliberate continence of defecation, malfunction, or disease.<sup>1,2</sup> <h3>Normal Physiology</h3> In the resting state, anus and rectum are empty and collapsed with their side walls closely approximated. The sigmoid colon, a narrowed segment with relatively high intraluminal pressure, functions as a partial sphincter to retain bowel content in the proximal reservoir of descending colon. Increased intra-abdominal pressure with muscular exertion or straining tends to collapse even more tightly the walls of the empty rectum above the levator muscles to reinforce the mechanisms of continence. In addition, the internal sphincter of the anus maintains a state
Complications of cutaneous scleroderma
Authors: P. Clavadetscher
Journal: JAMA (1975)

<h3>History</h3> A 61-year-old housewife first noted symptoms of Raynaud phenomenon and cutaneous scleroderma in 1963. Progressive dyspnea with pulmonary fibrosis and rightsided cardiac failure began in 1969. Since 1973, she has had intermittent episodes of cramping abdominal pain with nausea along with dyspnea, cough, and loss of weight. In November 1974, the patient was hospitalized because of progressive abdominal pain and vomiting. Physical examination demonstrated advanced skin changes of scleroderma, signs of pulmonary hypertension, and cardiac failure. The abdomen was distended but soft and nontender. Bowel sounds were normal. Results of laboratory studies were normal except for findings indicative of moderate malabsorption. Figures 1 through 3 were obtained on this admission. <h3>Diagnosis</h3> Scleroderma of the skin, lung, esophagus, and the small bowel, complicated by pneumatosis cystoides intestinalis and pneumoperitoneum. <h3>Comment</h3> The chest roentgenogram (Fig 1) shows diffuse pulmonary fibrosis and cor pulmonale as well as congestive heart failure. Free air
Contents
Authors: Mary Whitman, Katelyn Macneill, David Hunter, Jinhai Huang, Daizong Wen, Qinmei Wang, Colm Mcalinden, M Bch, Ian Flitcroft, Haisi Chen, Mei Saw, Hao Chen, Fangjun Bao, Yune Zhao, Liang Hu, Xuexi Li, Rongrong Gao, Weicong Lu, Yaoqiang Du, Zhengxuan Jinag, Ayong Yu, Hengli Lian, Qiuruo Jiang, Ye Yu, Jia Qu, Verity Oliver, Katherine Van Bysterveldt, Murray Cadzow, Bernhard Bbiomedsci, Vito Steger, David Romano, Alex Markie, David Hewitt, Colin Mackey, Trevor Willoughby, Philip Sherwin, Charles Crosier, Andrea Mcghee, Tsontcho Ianchulev, David Litoff, Donna Ellinger, Kent Stiverson, Mark Packer, Michelle Chan, Carlota Grossi, Anthony Khawaja, Jennifer Yip, Kay-Tee Khaw, Praveen Patel, Peng Khaw, James Morgan, Stephen Frcophth, Paul Frcophth, Tigran Kostanyan, Kyung Sung, Joel Schuman, Yun Ling, Katie Lucy, Richard Ba, Hiroshi Bilonick, Larry Ishikawa, Jin Kagemann, Gadi Lee
Journal: Ophthalmology (2016)
Table of Contents
Authors: Abbas Shafaee, Zarei Davood, Jalil Dastyar, Milad Islamian, Polyzois Makras, Sideris Delaroudis, Athanasios Anastasilakis, Konstantinos Tziomalos, Vasilios Athyros, Paschalis Paschos, Asterios Karagiannis, Hong-Tao Tie, Rui Shi, Zhen-Han Li, Min Zhang, Cheng Zhang, Qing-Chen Wu, Tamás Kitka, Sebestyén Tuza, Balázs Varga, Csilla Horváth, Péter Kovács
Journal: Metabolism (2015)
Highlights from this issue
Authors: A. Bush, I. Pavord
Journal: Thorax (2011)

October's theme: smokingAnd indeed there is no cure for any of the common smoking related diseases such as COPD, lung cancer, and ischaemic heart disease.So this issue of Thorax is dedicated without thanks to the Tobacco industry, and this section re-named in their dishonour.We hope SMOKEWAVES and especially this issue of the journal will serve as a ringing call to action to our legislators to curb the industry's exploitative activities among the young in particular.We do not need a second opinion from Phillip Morris!
Medical News
Journal: JAMA (1913)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Reduced Basal Ganglia Volumes After Switching to Olanzapine in Chronically Treated Patients With Schizophrenia
Authors: D. J. Lang
Journal: American Journal of Psychiatry (2004)

OBJECTIVE: A follow-up study of patients with schizophrenia was conducted to examine change in striatal volumes and extrapyramidal symptoms after a change in medication. METHOD: Thirty-seven patients with schizophrenia and 23 healthy volunteers were examined. Patients at baseline receiving typical antipsychotics (N=10) or risperidone but exhibiting limited response (N=13) were switched to treatment with olanzapine. Patients receiving risperidone and exhibiting a good response (N=14) continued treatment with risperidone. Caudate, putamen, and pallidal volumes were assessed with magnetic resonance imaging. The Extrapyramidal Symptoms Rating Scale was used to assess clinical signs and symptoms. RESULTS: At baseline, basal ganglia volumes in patients treated with typical antipsychotics were greater than in healthy subjects (putamen: 7.0% larger; globus pallidus: 20.7% larger). After the switch to olanzapine, putamen and globus pallidus volumes decreased (9.8% and 10.7%, respectively) and did not differ from those of healthy subjects at the follow-up evaluation. Akathisia was also reduced. In the patients receiving risperidone at baseline, basal ganglia volumes did not differ between those exhibiting good and poor response, and no significant volume changes were observed in subjects with poor risperidone response after the switch to olanzapine treatment. CONCLUSIONS: Olanzapine reversed putamen and globus pallidus enlargement induced by typical antipsychotics but did not alter volumes in patients previously treated with risperidone. Changes in striatal volumes related to typical and atypical antipsychotics may represent an interactive effect between individual medications and unique patient characteristics.
Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II Trial
Authors: Bixia Tang, Zhihong Chi, Yingbo Chen, Xiufeng Liu, Di Wu, Jing Chen, Xin Song, Weifeng Wang, Lihou Dong, Haifeng Song, Hai Wu, Hui Feng, Sheng Yao, Shuikui Qin, Xiaoshi Zhang, Jun Guo
Journal: Clinical Cancer Research (2020)

In contrast to the predominant chronic UV exposure-induced cutaneous melanoma in Caucasians, acral and mucosal comprise the majority of melanomas in Asia and respond less effectively to established treatments. The clinical application of PD-1 blockade is yet to be explored in metastatic melanoma in China.This phase II study was to evaluate safety and efficacy of toripalimab in advanced Chinese patients with melanoma who had failed in systemic treatments. Toripalimab was given at 3 mg/kg i.v. once every 2 weeks until disease progression or unacceptable toxicity. The primary objective was safety and objective response rate.128 Patients with melanoma were enrolled, including 50 acral and 22 mucosal. As of August 15, 2019, 23 months after the last enrollment, 116 (90.6%) experienced treatment-related adverse events. ≥Grade 3 TRAEs occurred in 25 (19.5%) patients. Among 127 patients assessed, 1 complete response, 21 partial response, and 51 stable disease were observed for objective response rate of 17.3% and disease control rate of 57.5%. Median duration of response was not reached. Median progression-free survival was 3.6 months [95% confidence interval (CI) 2.7-5.3] and median overall survival was 22.2 months (95% CI, 15.3-NE). Patients with positive PD-L1 staining in tumor biopsies had significant better ORR (38.5% vs. 11.9%, P = 0.0065), PFS (7.7 months vs. 2.7 months, P = 0.013), and OS (not reached vs. 14.4 months, P = 0.0005) than PD-L1-negative patients.This is the largest prospective anti-PD-1 clinical study in advanced melanoma with predominantly acral and mucosal subtypes. Toripalimab demonstrated a manageable safety profile and durable clinical response in Chinese patients with metastatic melanoma refractory to standard therapy.See related commentary by Shoushtari et al., p. 4171.
Effect of Exercise on Pulmonary Blood Volume
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Reduction of Sperm Motility in a Male Laboratory Worker Exposed to Solvents: A Case Study
Authors: Ho-Yuan Chang, Yung-Ming Lin, Ping-Chi Hsu, Yueliang Leon Guo
Journal: Environmental Health Perspectives (2001)

A 34-year-old male laboratory worker suffered from asthenospermia and fertility problems. He was suspected of having been exposed to solvents used at work due to a malfunction of the ventilation system in his laboratory from August 1996 to April 1997. A laboratory walk-through and air and bulk sample collection were performed to determine the possible exposure levels of chemical hazards in his job. The scenario was reconstructed to simulate the worker's previous exposure during the ventilation shutdown period. It was found that the worker was possibly exposed to chloroform at levels of 10 or 50 times higher than the permissible exposure limit or the threshold limit value of 2 hr/day, 5.5 days/week, and 4.25 weeks/month for 8 months. Because chloroform is known to be spermatotoxic, the possibility of chloroform causing the worker's asthenospermia cannot be ruled out. Further study on spermatotoxicity of chloroform is warranted.
EXPERIMENTAL SYPHILIS.
Journal: JAMA (1905)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Benefit of a High-Dose Epirubicin Regimen in Adjuvant Chemotherapy for Node-Positive Breast Cancer Patients With Poor Prognostic Factors: 5-Year Follow-Up Results of French Adjuvant Study Group 05 Randomized Trial
Journal: Journal of Clinical Oncology (2001)

PURPOSE: To determine the influence of the epirubicin dose in operable node-positive breast cancer patients with factors of poor prognosis. PATIENTS AND METHODS: Between April 1990 and July 1993, 565 operable breast cancer patients with either more than three positive nodes or between one and three positive nodes with Scarff Bloom Richardson grade ≥ 2 and hormone receptor negativity were randomized after surgery to receive either fluorouracil 500 mg/m 2 , epirubicin 50 mg/m 2 , and cyclophosphamide 500 mg/m 2 every 21 days for six cycles (FEC 50) or the same regimen except with epirubicin dose of 100 mg/m 2 (FEC 100). Postmenopausal patients received tamoxifen 30 mg/d for 3 years at the beginning of chemotherapy. Radiotherapy was delivered at the end of chemotherapy in both groups. RESULTS: The median follow-up was 67 months. The 5-year disease-free survival (DFS) was 54.8% with FEC 50 and 66.3% with FEC 100 (P = .03). The 5-year overall survival (OS) was 65.3% and 77.4%, respectively (P = .007). The mean relative dose-intensity was similar in the two groups (90.3% and 86.1%, respectively). Neutropenia and anemia were significantly more frequent in FEC 100 (P &lt; 10 − 3 ), as were nausea-vomiting (P = .008) and stomatitis and alopecia (P &lt; 10 − 3 ). Nine cases of grade 3 infection occurred only with FEC 100, and no toxic deaths occurred. Three cases of acute cardiac toxicity were observed (FEC50 = 1, FEC100 = 2) and 10 patients (FEC50 = 6, FEC100 = 4) presented delayed cardiac dysfunctions. Two cases of secondary leukemia were observed (acute lymphatic leukemia with FEC 50 and acute myelogenous leukemia with FEC 100). CONCLUSION: After 5 years of follow-up, the increased epirubicin dose led to a significant benefit in terms of DFS and OS, with a high survival rate among patients with poor-prognosis breast cancer.
Possible predictive tests for malignant hyperthermia during anesthesia
Authors: J. A. Aldrete
Journal: JAMA (1971)

A 17-year-old patient survived an episode of fulminant hyperpyrexia during anesthesia with methohexital sodium, nitrous oxide, halothane, and succinylcholine. Five months later, studies performed in his immediate family revealed high creatine phosphokinase (CPK) values in him and slightly elevated values in his mother, brother, sister, and one maternal uncle and grandmother. The patient, his mother, brother, and sister were also found to have elevated serum pyrophosphate (P-P). Upper borderline levels of lactic dehydrogenase occur at expenses of its fraction III. These tests may have possible predictive value in identifying susceptible patients.
Attitudes of medical students toward cannabis
Authors: L. P. Solursh
Journal: JAMA (1971)

A brief questionnaire about cannabis attitudes and use was distributed to senior medical classes at one Canadian (Ontario) and one US (California) university. In each case a high return rate was obtained. Responses from the two groups showed a number of similarities. However, the US students were significantly more likely to have used cannabis and to recognize the substance by sight or smell (when burning). Similarly, the California students were much more likely to exhibit permissive attitudes to occasional cannabis use in a patient and somewhat more likely to favor more liberal statutes regarding cannabis distribution and possession. A clear majority of both groups expected no significant effects of moderate cannabis use on either the physical or mental health of the user.
Emergency Aid Symbol Designed by AMA
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Re: cough-induced cardiac compression
Authors: J. M. Griley
Journal: JAMA (1977)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Gorham syndrome
Authors: G. Pedicelli
Journal: JAMA (1984)

<h3>History</h3> An 18-year-old woman was admitted to the hospital with a history of sudden onset of dyspnea, cough, fever, and pain in the left hemithorax. A posteroanterior roentgenogram of the chest (Fig 1) showed a large pleural effusion on the left side. A suggestive mass lesion was observed in the area of the aortic arch, projecting laterally into the left hemithorax. Gross alteration in the bony architecture of the left scapula and uppermost segment of the left humerus was identified, reflecting the presence of confluent, osteolytic lesions in these structures. The left clavicle also was affected. A left-sided thoracentesis was performed; 2,500 mL of chylous fluid was obtained. A posteroanterior roentgenogram of the left shoulder area (Fig 2) obtained eight years previously (when the patient was 10 years old) because of an attack of myositis showed similar abnormalities affecting the scapula, again manifested by the presence of multiple, confluent, osteolytic
FEDERAL CARE OF MATERNITY AND INFANCY: THE SHEPPARD-TOWNER BILL
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Book Review The Chronicle of Crichton Royal (1833–1936) . By Charles Cromhall Easterbrook, M.D., F.R.C.P. (Eng.). With a foreword, "Some Early Crichton Memories," by the late Sir James Crichton-Browne, M.D., LL.D., F.R.S. 4°, cloth, 663 pp., with 103 illustrations and 1 map. Dumfries, Scotland: Courier Press, 1940. 25 sh. net.
Journal: New England Journal of Medicine (1941)
Paternal Transmission of a 15/21 Translocation
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
B-Cell Count and Survival: Differentiating Chronic Lymphocytic Leukemia (CLL) from and Monoclonal B-Cell Lymphocytosis (MBL) Based on Clinical Outcome.
Authors: Tait Shanafelt, Neil E. Kay, Gregory Jenkins, Timothy G. Call, Clive S. Zent, Diane F. Jelinek, Justin Boysen, Susan Schwager, Deborah Bowen, Liam Zakko, Susan L. Slager, Curtis A. Hanson
Journal: Blood (2008)